Search - tctmd.com

Presenter: Hirotoshi Hariki, Junya Shite, Toshiro Shinke, Hiromasa Ootake, Masayuki Nakagawa, Ryouji Nagoshi, Takumi Inoue, Tsuyoshi Oosue, Amane Kozuki, Masamichi Iwasaki, Yu Taniguchi, Hiroto Kinutani, Akihide Konishi, Ryo Nishio, Noritoshi Hiranuma, Ken-ichi Hirata

January 03, 2012

Presentation TCT 2012

Five-Year Outcomes of Sirolimus-Eluting Stent in Patients with Unprotected Left Main Coronary Arteries: the Milan and New-Tokyo Registry.

Presenter: Kensuke Takagi, Alfonso Ielasi, Joanne Shannon, Azeem Latib, Cosmo Godino, Giedrius Davidavicius, Marco Mussardo, Santo Ferrarello, Mauro Carlino, Matteo Montorfano, Alaide Chieffo, Sunao Nakamura, Antonio Colombo

January 03, 2012

Presentation TCT 2012

5-year results of treatment of Unprotected Left Main Stenosis by CABG or PCI with Sirolimus eluting stent. A multicenter, randomized trial

Presenter: Enno Boudriot, Holger Thiele, Franz J. Neumann, Michael Gick, Bruno Reichard, Peter Boekstegers, Harald Mudra, Florian Beier, Thomas Walther, Friedrich W. Mohr, Gerhard Schuler

January 03, 2012

News Daily News

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

September 14, 2011

News Daily News

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Jason Kahn

September 12, 2011

Advertisement

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

SES Show Advantage Over ZES, PES for Diabetic Patients

Novel Stent Helps Treat Bifurcation Lesions in FIM Registry

Nordic Bifurcation Study at 5 Years: Stick to Simple Stenting Strategy

TCT-41. The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated with the Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and...

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

Stent Thrombosis Surprise: Rates Low, Similar for Endeavor and Cypher at 3 Years

SORT OUT III: Higher Risk of Very Late Stent Thrombosis with Cypher vs. Endeavor

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

TCTMD’s Top 10 Most Popular News Stories From 2011

Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist

Very Late Stent Thrombosis and Late TLR After Sirolimus-Eluting Stent Implantation

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Long-term follow up of sirolimus-eluting stent(SES) implanted in coronary bifurcation lesion: Insight from OCT observations

Five-Year Outcomes of Sirolimus-Eluting Stent in Patients with Unprotected Left Main Coronary Arteries: the Milan and New-Tokyo Registry.

5-year results of treatment of Unprotected Left Main Stenosis by CABG or PCI with Sirolimus eluting stent. A multicenter, randomized trial

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content